Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Location
360 Massachusetts Avenue, Suite 203, Acton, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 460 % +84.3%
Debt-to-equity 22.6 % -54.2%
Return On Equity -114 % +47.7%
Return On Assets -93.2 % +36.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 554K shares -79.4%
Common Stock, Shares, Outstanding 554K shares -79.4%
Entity Public Float 1.7M USD -43.9%
Common Stock, Value, Issued 55 USD -79.6%
Weighted Average Number of Shares Outstanding, Basic 554K shares +9293%
Weighted Average Number of Shares Outstanding, Diluted 554K shares +9293%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.92M USD -48.7%
Selling and Marketing Expense 305 USD -99.8%
General and Administrative Expense 3.71M USD -12.2%
Operating Income (Loss) -6.63M USD +34.1%
Nonoperating Income (Expense) 24.5K USD -75.4%
Net Income (Loss) Attributable to Parent -7.25M USD +25.5%
Earnings Per Share, Basic 277 USD/shares +99.1%
Earnings Per Share, Diluted 277 USD/shares +99.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.12M USD +17.1%
Assets, Current 3.57M USD +3.55%
Property, Plant and Equipment, Net 1.5M USD +14.9%
Operating Lease, Right-of-Use Asset 176K USD -41%
Other Assets, Noncurrent 34.4K USD +36.6%
Assets 5.28M USD +4%
Accounts Payable, Current 520K USD +91.1%
Accrued Liabilities, Current 552K USD -50.6%
Liabilities, Current 1.32M USD -13.7%
Operating Lease, Liability, Noncurrent 87.4K USD -48.8%
Other Liabilities, Noncurrent 7.58K USD -33.5%
Liabilities 1.41M USD -17.3%
Retained Earnings (Accumulated Deficit) -36.5M USD -24.8%
Stockholders' Equity Attributable to Parent 3.87M USD +14.8%
Liabilities and Equity 5.28M USD +4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.18M USD +48.5%
Net Cash Provided by (Used in) Financing Activities -985K USD -135%
Net Cash Provided by (Used in) Investing Activities -35.4K USD +89.6%
Common Stock, Shares Authorized 250M shares +3233%
Common Stock, Shares, Issued 554K shares -79.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.12M USD +17.1%
Deferred Tax Assets, Valuation Allowance 10M USD +30.4%
Deferred Tax Assets, Gross 10M USD +30.4%
Operating Lease, Liability 187K USD
Depreciation 18.4K USD -6.66%
Payments to Acquire Property, Plant, and Equipment 35.4K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 200K USD
Property, Plant and Equipment, Gross 1.71M USD -33.4%
Operating Lease, Liability, Current 100K USD -31.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 100K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 25K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 6.36M USD +39.6%
Operating Lease, Payments 38.3K USD -13.5%
Share-based Payment Arrangement, Expense 9.53K USD -89%
Interest Expense 186K USD